DUNNE MICHAEL W. (Chief Scientific Officer) purchased 34.0% of their position (20K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $40.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/27/2023ACC: 0001209191-23-056685
Officer· Chief Scientific Officer
Since Aug 2018
+20K
Net shares
Net buyer
$40.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+20K
Price / share
$2.03
Trade value
$40.69K
% of position
34.0%
11/22/2023
58.75K→78.75K
Total
Net shares
+20K
Net value
$40.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/22/2023 | P · Purchase | +20K | $2.03 | $40.69K | 34.0% | 58.75K | 78.75K |
| Total | +20K | $40.69K | ||||||
Derivative Transactions0
No derivative transactions reported